Great West Life Assurance CO Viking Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 82,416 shares of VKTX stock, worth $5.35 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
82,416
Previous 76,636
7.54%
Holding current value
$5.35 Million
Previous $6.3 Million
30.71%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding VKTX
# of Institutions
443Shares Held
63.4MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$656 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$391 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$333 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$146 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$121 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.98B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...